1 In vitro Biology; 2 in vivo Pharmacology, 3 In silico R&D, 4 Bioinformatics, 5 Proteomics & Metabolomics, Evotec, Campus Curie, Toulouse, France; 6 in vitro Biology, Evotec, Hamburg, Germany; 7 Academic Partnerships, 8 Global Protein Sciences, Structural Biology,Milton Park, Abingdon, UK; 9 Drug Discovery Chemistry, 10 Discovery DMPK, Verona, Italy, 11 Safety Assessment and Strategy, 12 In vitro Biology, Milton Park, Abingdon, UK. 
Correspondence: Steve Durant, VP, Scientific Director, stephen.durant@evotec.com